ThermoGenesis Holdings, Inc. (THMO)

Market Cap	16.00 -99.0%
Revenue (ttm)	9.61M -7.5%
Net Income	-14.75M
EPS	-4.82
Shares Out	15.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.000001 - 0.0001
Beta	16.81
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About ThermoGenesis Holdings

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 25
• Stock Exchange: OTCMKTS
• Ticker Symbol: THMO

Financial Performance

In 2023, ThermoGenesis Holdings's revenue was $9.45 million, a decrease of -9.90% compared to the previous year's $10.48 million. Losses were -$17.98 million, 59.5% more than in 2022.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 18, 2026

Data Sources Report a data error